Hospira Inc - Current report filing (8-K)
28 Abril 2008 - 10:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
April 24, 2008
Date of Report
(Date of Earliest Event Reported)
HOSPIRA, INC.
(Exact Name of
Registrant as Specified in Its Charter)
Delaware
(State or Other
Jurisdiction of Incorporation)
1-31946
|
|
20-0504497
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
275 N. Field Drive
Lake Forest, Illinois 60045
(Address Of Principal Executive Offices, including Zip Code)
Registrants Telephone Number, Including Area Code:
(224) 212-2000
Not Applicable
(Former Name or
Former Address, If Changed Since Last Report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
FORWARD-LOOKING STATEMENTS
This
report contains forward-looking statements within the meaning of the federal
securities laws, including, without limitation, the planned time frames for the
activities described in this report, the estimated total and cash charges
relating to such activities, the timing and amount of the expected cost savings
from such activities, and other statements regarding Hospiras plans,
objectives and strategies. Hospira
cautions that these forward-looking statements are subject to risks and
uncertainties that may cause actual results to differ materially from those
indicated in the forward-looking statements.
Factors, risks and uncertainties that may affect Hospiras operations
and may cause actual results to be materially different from expectations
include Hospiras ability to effectively transition the manufacturing at the
affected facility to other manufacturing facilities and/or outsource such
manufacturing to third party suppliers, the cost and availability of such
manufacturing or outsourcing, uncertainties regarding the number of affected
employees and employee-related and other costs and the risks and uncertainties
set forth under the headings Risk Factors and Managements Discussion and
Analysis of Financial Condition and Results of Operations in Hospiras latest
Annual Report on Form 10-K filed with the Securities and Exchange
Commission, which is incorporated by reference.
Hospira undertakes no obligation to release publicly any revisions to
forward-looking statements as the result of subsequent events or developments.
Item 2.05
Costs
Associated with Exit or Disposal Activities
On
April 24, 2008, Hospira announced a plan to exit its manufacturing
operations at its Morgan Hill, California plant and transfer most of the operations
to other Hospira locations or other third parties over the next two to three
years. The relatively higher costs of
manufacturing in the impacted facility prompted this action. Some product support and manufacturing
positions will remain in Morgan Hill.
Hospira
estimates that the plan will result in pre-tax charges to its earnings in the
range of approximately $29 million to $35 million, which are expected to be
recorded over the next three years, beginning in the second quarter of 2008. Of these charges, approximately $24 million
to $30 million will be cash related. The
cash related charges do not include capital expenditures related to
establishing capacity in any new locations or the eventual proceeds from the
sale of the existing facility in Morgan Hill.
Estimates
of the total pre-tax charges Hospira expects to incur for each major type of
cost associated with the plan are: (i) $18
million to $22 million for employee-related costs, including costs for
severance, retention and other assistance; (ii) $6 million to $8 million
for other cash costs associated with the plan; and (iii) approximately $5
million in other non-cash charges, including accelerated depreciation of plant
assets. The annual savings associated
with these actions are expected to reach approximately $15 million after-tax
beginning in 2011.
2
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
HOSPIRA,
INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
Date:
April 28, 2008
|
|
|
/s/ Brian J. Smith
|
|
|
|
By: Brian J. Smith
|
|
|
|
Its: Senior Vice President, General Counsel and
Secretary
|
3
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024